文献速递脑血管病外科神经重症

VEGF水平升高加重小鼠脑动静脉畸形出血

Effect of elevation of vascular endothelial growth factor level on exacerbation of hemorrhage in mouse brain arteriovenous malformation.
PubMed 文献 · J Neurosurg · 2019-04-26

研究采用小鼠bAVM模型,通过不同剂量AAV-VEGF及颈静脉高压诱导,发现高剂量VEGF组VEGF水平更高(p=0.003)、Prussian蓝阳性面积更大(p=0.002),且死亡率达26.7%,而低剂量无VH组无死亡,VH使低剂量组死亡率达50%。结论提示VEGF水平升高直接加重bAVM出血和死亡。

要点

  • 高剂量VEGF加重小鼠bAVM出血,Prussian蓝阳性面积显著增大(p=0.002)。
  • 高剂量VEGF组总死亡率为26.7%,低剂量无VH组无死亡。
  • 静脉高压使低剂量VEGF组死亡率升至50%。

核心结论

  • VEGF水平升高直接加重小鼠bAVM出血并增加死亡率。

研究设计与样本

  • 成年小鼠基底节注射表达Cre的腺病毒诱导Alk1突变及AAV-VEGF诱导血管生成,建立bAVM模型。
  • 使用高剂量(5×10^9)和低剂量(2×10^9)AAV-VEGF病毒基因组。
  • 部分低剂量组小鼠在模型诱导6周后行颈总动脉-颈外静脉吻合以诱导脑静脉高压。
  • 模型诱导8周后收集脑样本,用Prussian蓝染色定量出血,ELISA定量VEGF。

主要发现

  • 高剂量组VEGF水平高于低剂量组(p=0.003)。
  • 高剂量组bAVM病灶Prussian蓝阳性面积大于低剂量组(p=0.002)。
  • 静脉高压增加低剂量AAV-VEGF组bAVM出血。
  • 高剂量组总死亡率为26.7%,低剂量无VH组无死亡。
  • 静脉高压使低剂量组死亡率为50%。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: A high level of vascular endothelial growth factor (VEGF) has been implicated in brain arteriovenous malformation (bAVM) bleeding and rupture. However, direct evidence is missing. In this study the authors used a mouse bAVM model to test the hypothesis that elevation of focal VEGF levels in bAVMs exacerbates the severity of bAVM hemorrhage. METHODS: Brain AVMs were induced in adult mice in which activin receptor-like kinase 1 (Alk1, a gene that causes AVM) gene exons 4-6 were floxed by intrabasal ganglia injection of an adenoviral vector expressing Cre recombinase to induce Alk1 mutation and an adeno-associated viral vector expressing human VEGF (AAV-VEGF) to induce angiogenesis. Two doses of AAV-VEGF (5 × 109 [high] or 2 × 109 [low]) viral genomes were used. In addition, the common carotid artery and external jugular vein were anastomosed in a group of mice treated with low-dose AAV-VEGF 6 weeks after the model induction to induce cerebral venous hypertension (VH), because VH increases the VEGF level in the brain. Brain samples were collected 8 weeks after the model induction. Hemorrhages in the bAVM lesions were quantified on brain sections stained with Prussian blue, which detects iron deposition. VEGF levels were quantified in bAVM tissue by enzyme-linked immunosorbent assay. RESULTS: Compared to mice injected with a low dose of AAV-VEGF, the mice injected with a high dose had higher levels of VEGF (p = 0.003) and larger Prussian blue-positive areas in the bAVM lesion at 8 or 9 weeks after model induction (p = 0.002). VH increased bAVM hemorrhage in the low-dose AAV-VEGF group. The overall mortality in the high-dose AAV-VEGF group was 26.7%, whereas no mouse died in the low-dose AAV-VEGF group without VH. In contrast, VH caused a mortality of 50% in the low-dose AAV-VEGF group. CONCLUSIONS: Using mouse bAVM models, the authors provided direct evidence that elevation of the VEGF level increases bAVM hemorrhage and mouse mortality.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Cheng P, Ma L, Shaligram S, et al. Effect of elevation of vascular endothelial growth factor level on exacerbation of hemorrhage in mouse brain arteriovenous malformation. J Neurosurg. 2019. PMID: 31026826. doi:10.3171/2019.1.JNS183112

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。